FDA Approved: DOXYCYCLINE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for doxycycline from Par Health USA, LLC under an ANDA, authorizing changes to the generic product and its labeling.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Chlamydial Infections
• Gonorrhea
• Lyme Disease
• Malaria
• Pneumonia Due to Mycoplasma Pneumoniae
• Rickettsial Diseases

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

SUPPL AP for DOXYCYCLINE (DOXYCYCLINE)